← Open Payments lookup

KENT BRAEUTIGAM: Open Payments

NPI 1063437861 · MIDDLEBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,297 in 120 payments from 24 companies in 2025. Trend: 2023 $2,516 · 2024 $1,811 · 2025 $2,297

Food & beverage: $2,297
CompanyPaymentsAmount
ABBVIE INC.16$295
AstraZeneca Pharmaceuticals LP9$286
Lilly USA, LLC14$228
Novo Nordisk Inc12$216
Vanda Pharmaceuticals Inc.12$194
Amgen Inc.14$193
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$103
SANOFI-AVENTIS U.S. LLC4$102
Biogen, Inc.3$84
Otsuka America Pharmaceutical, Inc.4$83

Products named: BREZTRI, VRAYLAR, FANAPT, REXULTI, MOUNJARO, Wegovy, CAPLYTA, TZIELD.

Industry payments across FL — which companies pay providers there.